CAHIC(SH:600195) Ge Long Hui A P P·2026-01-28 08:17Core Viewpoint - The company expects a significant increase in net profit for the year 2025, driven by strategic investments and operational optimizations [1] Financial Performance - The projected net profit attributable to shareholders for 2025 is between 148.59 million and 192.29 million yuan, representing a year-on-year increase of 109.62% to 171.27% [1] - The expected net profit after deducting non-recurring gains and losses is estimated to be between 16.90 million and 23.24 million yuan, indicating a year-on-year decrease of 62.60% to 72.80% [1] Strategic Actions - The company plans to subscribe to convertible bonds issued by Xiamen Jindawei Group Co., Ltd., while waiving the preemptive rights for shares in Zhongpu Biopharmaceutical Co., Ltd. [1] - There is a significant increase in fair value changes and investment income, contributing to the rise in net profit [1] - The company is actively responding to multiple pressures by optimizing its marketing structure, exploring customer needs, developing new products, and expanding new business [1] Operational Management - The company has strengthened its overall management of daily operations, aiming to enhance cost reduction and efficiency [1] - The market share of the company's products remains resilient and vibrant, with stable and orderly production and operations [1]